These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 19293188)
1. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188 [TBL] [Abstract][Full Text] [Related]
2. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells. Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074 [TBL] [Abstract][Full Text] [Related]
3. SYK is a target of lymphocyte-derived microparticles in the induction of apoptosis of human retinoblastoma cells. Qiu Q; Yang C; Xiong W; Tahiri H; Payeur M; Superstein R; Carret AS; Hamel P; Ellezam B; Martin B; Vezina M; Sapieha P; Liu G; Hardy P Apoptosis; 2015 Dec; 20(12):1613-22. PubMed ID: 26404525 [TBL] [Abstract][Full Text] [Related]
4. Advances in melanoma senescence and potential clinical application. Giuliano S; Ohanna M; Ballotti R; Bertolotto C Pigment Cell Melanoma Res; 2011 Apr; 24(2):295-308. PubMed ID: 21143770 [TBL] [Abstract][Full Text] [Related]
5. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms]. Wang HY; Zhang ZX Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952 [TBL] [Abstract][Full Text] [Related]
6. Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells. Yang WS; Chang JW; Han NJ; Lee SK; Park SK Exp Cell Res; 2012 Sep; 318(15):1867-76. PubMed ID: 22659134 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Muthusamy V; Duraisamy S; Bradbury CM; Hobbs C; Curley DP; Nelson B; Bosenberg M Cancer Res; 2006 Dec; 66(23):11187-93. PubMed ID: 17145863 [TBL] [Abstract][Full Text] [Related]
8. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Yuan Y; Liu H; Sahin A; Dai JL Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373 [TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887 [TBL] [Abstract][Full Text] [Related]
12. Status of RASSF1A in uveal melanocytes and melanoma cells. Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308 [TBL] [Abstract][Full Text] [Related]
13. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005 [TBL] [Abstract][Full Text] [Related]
14. Cooperation between p21 and Akt is required for p53-dependent cellular senescence. Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365 [TBL] [Abstract][Full Text] [Related]
15. The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. Rajarajacholan UK; Thalappilly S; Riabowol K PLoS Biol; 2013; 11(3):e1001502. PubMed ID: 23472054 [TBL] [Abstract][Full Text] [Related]
16. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797 [TBL] [Abstract][Full Text] [Related]
17. Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression. Mackenzie Ross AD; Cook MG; Chong H; Hossain M; Pandha HS; Bennett DC Pigment Cell Melanoma Res; 2013 Mar; 26(2):226-35. PubMed ID: 23253087 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway. Li Q; Li J; Wen T; Zeng W; Peng C; Yan S; Tan J; Yang K; Liu S; Guo A; Zhang C; Su J; Jiang M; Liu Z; Zhou H; Chen X Oncotarget; 2014 Aug; 5(15):6387-403. PubMed ID: 25051367 [TBL] [Abstract][Full Text] [Related]
19. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280 [TBL] [Abstract][Full Text] [Related]
20. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]